Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-Response.

Trial Profile

Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-Response.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Dec 2016

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Major depressive disorder
  • Focus Pharmacodynamics; Pharmacogenomic
  • Most Recent Events

    • 28 Oct 2016 Status changed from recruiting to completed.
    • 01 Oct 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Oct 2014 to 1 Dec 2014.
    • 17 Oct 2013 Planned end date changed from 26 Jan 2014 to 1 Oct 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top